Kopran shares climb 10% after USFDA approves DMF of Atenolol filed by subsidiary

The company can commence supplies of the API Atenolol to the US market, Kopran said in its BSE filing.
18-06-2020
Bigul

KOPRAN LTD. - 524280 - Updates

The Active Pharmaceutical Ingredients Manufacturing facility at Mahad of Kopran Research Laboratories Limited, a 100 percent subsidiary of Kopran Limited was inspected by the USFDA in January 2019 without any observation under Para 483. This was notified to the Stock Exchange on 25th January 2019. The Company had filed the DMF of Atenolol which has now been approved by the USFDA and the Company can commence supplies of the API Atenolol to the US market.
18-06-2020
Bigul

KOPRAN LTD. - 524280 - Disclosure Of Material Impact Of COVID-19 Pandemic On The Operations Of The Company

Disclosure of Material Impact of COVID-19 pandemic on the Operations & financials of the Company
01-06-2020
Bigul

KOPRAN LTD. - 524280 - Compliance Certificate Under Reg 7(3) For The Period Ended 31.03.2020

Compliance Certificate under Reg 7(3) for the period ended 31.03.2020
07-05-2020
Bigul

KOPRAN LTD. - 524280 - Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2020.

Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2020, dated 20th April, 2020 issued by Ms. Nirali Mehta, Practicing Company Secretary (Membership No. A37734, COP No. 20754).
21-04-2020
Bigul

KOPRAN LTD. - 524280 - Shareholding for the Period Ended March 31, 2020

Kopran Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
17-04-2020
Bigul

KOPRAN LTD. - 524280 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunil Radheyshyam SodhaniDesignation :- Company Secretary and Compliance Officer
16-04-2020
Bigul

KOPRAN LTD. - 524280 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Kopran Ltd has Clarified to BSE that "This is with reference to your email L/SURV/ONL/PV/NK/2019-2020 /1282 dated 01st April, 2020 relating to the spurt in price movement on the exchanges. In this regard, we would like to bring to your kind attention that the Company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time and has not withheld any material information/event which in our opinion would have a bearing on the price/volume behavior on our scrip. The spurt in volume of our scrip /increase in the share price is purely market driven. The Company has been regularly sharing all information/announcements with the stock Exchange that have a bearing on the price/volume behavior on the scrip. We have been strictly following all the listing norms for disclosures, insider trading with the stock exchanges and there is no pending compliance on our part."
03-04-2020
Bigul

KOPRAN LTD. - 524280 - Clarification sought from Kopran Ltd

The Exchange has sought clarification from Kopran Ltd on 01st April, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
01-04-2020
Bigul

KOPRAN LTD. - 524280 - Closure of Trading Window

The 'Trading Window' for dealing in the securities of the Company will remain closed for Directors, Designated Employees and Connected Persons from April 01, 2020 till 48 (forty eight) hours after the declaration of Audited Financial Results of the Company for the Fourth quarter & year ended March 31, 2020.
31-03-2020
Next Page
Close

Let's Open Free Demat Account